Who
Andrew James King
Officer
Company insider
Files Form 4 as: Officer, Jade Biosciences; Chief Scientific Officer, Chinook Therapeutics.
In numbers
- Trades disclosed
- 70
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $1.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Oct 2020
- Last trade
- 12 Feb 2026
- Last filed
- 13 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Feb 2026filed 13 Feb 2026 | JBIO Jade BiosciencesBiotechnology | SEC FORM 4 Code A | —41,250 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | JBIO Jade Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —247,500 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | JBIO Jade Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —247,500 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | JBIO Jade BiosciencesBiotechnology | SEC FORM 4 Code A | —41,250 at $0.00 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $1.7M43,047 at $39.65 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $2.9M73,047 at $39.58 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $2.3M89,545 at $25.23 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $1.5M60,000 at $24.86 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $482K21,500 at $22.41 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $2.7M100,000 at $27.10 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | $1.5M104,000 at $14.73 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —10,152 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —6,802 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —16,667 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —6,667 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —26,000 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code D | —8,400 | filing |
| 11 Aug 2023filed 11 Aug 2023 | Chinook Therapeutics | SEC FORM 4 Code D | —19,157 | filing |
| 1 Aug 2023filed 1 Aug 2023 | Chinook Therapeutics | SEC FORM 4 Sold | $46K1,168 at $39.03 | filing |
| 29 Jul 2023filed 1 Aug 2023 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code M | —3,333 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.